[go: up one dir, main page]

WO2001097750A3 - Method for producing an antiviral agent - Google Patents

Method for producing an antiviral agent Download PDF

Info

Publication number
WO2001097750A3
WO2001097750A3 PCT/RU2001/000255 RU0100255W WO0197750A3 WO 2001097750 A3 WO2001097750 A3 WO 2001097750A3 RU 0100255 W RU0100255 W RU 0100255W WO 0197750 A3 WO0197750 A3 WO 0197750A3
Authority
WO
WIPO (PCT)
Prior art keywords
producing
antiviral agent
lignin
medicinal
inventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2001/000255
Other languages
French (fr)
Russian (ru)
Other versions
WO2001097750A2 (en
Inventor
Valery Afanasievich D Trofimov
Valery Pavlovich Shipov
Evgeny Sergeevich Pigarev
Aleksandr Ivanovich Popov
Viktor Nikolaevich Ivanov
Galina Sergeevna Shitikova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobel LLC
Original Assignee
Nobel LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel LLC filed Critical Nobel LLC
Priority to AU2001277823A priority Critical patent/AU2001277823A1/en
Publication of WO2001097750A2 publication Critical patent/WO2001097750A2/en
Publication of WO2001097750A3 publication Critical patent/WO2001097750A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The inventive method for producing an antiviral agent consists in treating platinite potassium with the ammonium salt of carboxylic acid which is embodied in the form of humic acids extracted from oxigenized medicinal lignin which are produced with the aid of air oxidation of the medicinal lignin in an alkaline medium at a temperature ranging from 150 °C to 170 °C and at a pressure ranging between 2.0 and 2.5 MPa during 0.5-1.5 hours. The inventive agent displays pronounced potency in relation to a herpes simplex virus of the first and second serotype variety and to influenza and Routh's sarcoma viruses.
PCT/RU2001/000255 2000-06-19 2001-06-15 Method for producing an antiviral agent Ceased WO2001097750A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001277823A AU2001277823A1 (en) 2000-06-19 2001-06-15 Method for producing an antiviral agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000115399/14A RU2172176C1 (en) 2000-06-19 2000-06-19 Method of antiviral agent preparing
RU2000115399 2000-06-19

Publications (2)

Publication Number Publication Date
WO2001097750A2 WO2001097750A2 (en) 2001-12-27
WO2001097750A3 true WO2001097750A3 (en) 2002-03-07

Family

ID=20236225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2001/000255 Ceased WO2001097750A2 (en) 2000-06-19 2001-06-15 Method for producing an antiviral agent

Country Status (3)

Country Link
AU (1) AU2001277823A1 (en)
RU (1) RU2172176C1 (en)
WO (1) WO2001097750A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104245800A (en) * 2012-03-30 2014-12-24 Rd创新有限公司 New benzene polycarboxylate

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178702C1 (en) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Anticancer agent
RU2678986C1 (en) * 2018-03-23 2019-02-05 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Antiviral agent based on humic acids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419351A (en) * 1977-06-03 1983-12-06 Research Corporation Platinum-dioxopyrimidine complexes
US4873226A (en) * 1983-06-17 1989-10-10 Delta Metals, Inc. Method of inhibiting herpetic lesions by the use of platinum coordination compounds
RU2104016C1 (en) * 1990-05-27 1998-02-10 Шантал Мах Method of preparing an aqueous solution containing active antiviral substances

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419351A (en) * 1977-06-03 1983-12-06 Research Corporation Platinum-dioxopyrimidine complexes
US4873226A (en) * 1983-06-17 1989-10-10 Delta Metals, Inc. Method of inhibiting herpetic lesions by the use of platinum coordination compounds
RU2104016C1 (en) * 1990-05-27 1998-02-10 Шантал Мах Method of preparing an aqueous solution containing active antiviral substances

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IZOBRETENIYA, no. 1, 10 January 1997 (1997-01-10), MOSCOW, VNIIPI, pages 22 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104245800A (en) * 2012-03-30 2014-12-24 Rd创新有限公司 New benzene polycarboxylate

Also Published As

Publication number Publication date
RU2172176C1 (en) 2001-08-20
WO2001097750A2 (en) 2001-12-27
AU2001277823A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AU2002311886A1 (en) Process for preparing purified shilajit composition from native shilajit
WO2001047928A3 (en) Imidazo 1,3,5 triazinones and the use thereof
CA2332756A1 (en) Method for producing expandable graphite intercalation compounds using phosphoric acids
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
EP1138955A3 (en) Method and apparatus for increasing the efficiency of a multi-stage compressor
WO2000023407A3 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
CA2258768A1 (en) A process for the preparation of tetraazamacrocycles
EP1203765A3 (en) Process for the synthesis of urea
AU6194998A (en) Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition
WO2003032907A3 (en) High-concentration protein formulations and method of manufacture
EP0885881A3 (en) Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
WO2003044210A3 (en) Process for preparing insulin compounds
MY140392A (en) Powder of amino acids and method for producing the same
CA2440931A1 (en) Hiv protease inhibitors based on amino acid derivatives
WO2001097750A3 (en) Method for producing an antiviral agent
EP0670371A3 (en) Process for producing optically active 4-hydroxy-2-ketoglutaric acids
WO2002000615A3 (en) Process for the isolation of lovastatin
ES2184302T3 (en) PROCEDURE FOR PREPARATION OF THE ACID 1,4,7,10-TETRAAZACICLODODECANO-1,4,7-TRIACETICO AND DERIVATIVES OF THE SAME.
AU5209900A (en) Copolymers with amphiphilic sub-units, a method for producing the same and the use thereof
WO1994028153A3 (en) Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
EP1415985A4 (en) Process for producing optically active azetidine-2-carboxylic acid
ATE151747T1 (en) METHOD AND DEVICE FOR PRODUCING UREA
BG99197A (en) Means for the treatment of cataract and method for its preparation
CA2327056A1 (en) Phosphine reduction of azides to amides
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BG BR CA CN CZ DE DK EE ES FI GB GE HR HU IL IN IS JP KE KR KZ LT LV NO NZ PL PT SE SK TR UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BG BR CA CN CZ DE DK EE ES FI GB GE HR HU IL IN IS JP KE KR KZ LT LV NO NZ PL PT SE SK TR UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC.(EPO LETTER FORM 1205A HAS BEEN SENT ON 10/06/2003)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP